Management of Glucocorticoid-Induced Osteoporosis – for Neurologists

Juliet Compston

doi:10.1111/j.1474-7766.2004.00251.x

Article menu

Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts

PDF

Therapeutic Intervention

Management of Glucocorticoid-Induced Osteoporosis – for Neurologists

Share this article

Click the icon of the social media platform on which you would like to share this article.

Share This Article:

Email this article to a friend

We will not keep your email address; we ask for it so your friend knows the email isn't spam.

Your email: *

Your name: *

Send to: *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Management of Glucocorticoid-Induced Osteoporosis – for Neurologists

Message subject: (Your Name) has forwarded a page to you from Practical Neurology

Message body: (Your Name) thought you would like to see this page from the Practical Neurology web site.

Your personal message:

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Read the full text or download the PDF:

Log in using your username and password

For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?

Forgot your user name or password?

Other content recommended for you

Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study
Shahab Abtahi et al., Annals of the Rheumatic Diseases, 2020
Glucocorticoid-induced osteoporosis
Karine Briot et al., RMD Open, 2015
Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density
Corinne Klop et al., Annals of the Rheumatic Diseases, 2016
Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids
I A Campbell et al., Thorax, 2004
What is osteoporosis?
C Christodoulou et al., Postgraduate Medical Journal, 2003
Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study
P C Souverein et al., Heart, 2004
The pathogenesis, diagnosis, investigation and management of osteoporosis
Sunita K Sandhu et al., Journal of Clinical Pathology, 2011
From bone biology to clinical outcome: state of the art and future perspectives
Georg Schett et al., Annals of the Rheumatic Diseases, 2010
Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study
Kristine E Ensrud et al., BMJ: British Medical Journal, 2014
Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study
D Vosse et al., Annals of the Rheumatic Diseases, 2008

Log in using your username and password

Main menu

Log in using your username and password

You are here

Share this article

Email this article to a friend

Request permissions

Read the full text or download the PDF:

Log in using your username and password

Other content recommended for you